Search Awardees

Neurexis Therapeutics LogoNeurexis Therapeutics

UEI: H6VMU4FMUAF5 • CAGE: 8J7Z1

Overview

Awardee Type
Parent
Company Description
Neuroprotective Innovationfor Human Health Stroke and cardiac arrest affect millions of patients each year. Re-establishment of blood flow to the brain—although life-saving—does not address the substantial impact on quality of life and healthcare costs associated with the resulting neuronal death and cognitive impairment. No drugs are available, leaving a tremendous market opportunity for a product
Name
Neurexis Therapeutics
Headquarters
Aurora, CO
United States
Federal grant recipient NEUREXIS THERAPEUTICS, INC. dba NEUREXIS THERAPEUTICS INC (UEI H6VMU4FMUAF5, CAGE 8J7Z1) is headquartered in Aurora CO. Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). The corporation was founded in February 2020 and federally registered in March 2020.

Federal Award Analysis

Neurexis Therapeutics federal award history

$-

Contracts

$-

Subcontracts

$-

Grants

$-

Subgrants

$-

Total

Interactive Stacked Bar Chart


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating
Year Contracts Subcontracts Grants Subgrants


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating

Federal Registration and Certifications

Legal Name
NEUREXIS THERAPEUTICS, INC.
DBA
NEUREXIS THERAPEUTICS INC
UEI
H6VMU4FMUAF5
CAGE Code
8J7Z1
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)

People

Vendor contacts at Neurexis Therapeutics

Subscribe to find 500K+ key government decision markers

Free Trial Schedule Demo

Grant Awards

Neurexis Therapeutics direct grants